531569 Q4 FY26 Earnings Call Transcript & Analysis
Consolidated Revenue 132.1 million; Consolidated EBITDA 21.73 million; Consolidated EBITDA Margin 15.74%. Consolidated revenue of INR 132.1 million in Q4 FY26.
Read full transcript & analysis
Every earnings call for 531569 — management tone, guidance, KPIs and promise tracking, quarter by quarter.
531569 · 6 transcripts · Healthcare · latest Q4 FY26Consolidated Revenue 132.1 million; Consolidated EBITDA 21.73 million; Consolidated EBITDA Margin 15.74%. Consolidated revenue of INR 132.1 million in Q4 FY26.
Read full transcript & analysisConsolidated Revenue ₹22 cr (+27% YoY); Consolidated EBITDA ₹14 cr (+45% YoY); Consolidated EBITDA Margin 18.5%. Consolidated Revenue grew 27.1% YoY to INR 22.1 crores.
Read full transcript & analysisRevenue ₹16 cr (−14% YoY); EBITDA ₹2 cr (−26% YoY); EBITDA Margin 15.5%. Revenue for Q2 FY26 stood at INR 15.5 crores, marking a 14.5% decline year-on-year.
Read full transcript & analysisRevenue ₹18 cr (+9% YoY); EBITDA ₹3 cr (+11% YoY); EBITDA Margin 15.0%. Revenue grew 8.9% YoY to INR17.9 crores.
Read full transcript & analysisFY25 Revenue ₹70 cr (+29% YoY); FY25 EBITDA ₹12 cr (+32% YoY); FY25 EBITDA Margin 16.5%. Q4 FY25 Revenue grew 41.3% YoY to INR 18.2 crores.
Read full transcript & analysisQ3 FY25 Revenue ₹17 cr (+16% YoY); Q3 FY25 EBITDA ₹3 cr (+29% YoY); Q3 FY25 EBITDA Margin 16.5%. Q3 FY25 Revenue was INR17.4 crores, a 15.9% YoY growth.
Read full transcript & analysis